Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Cryoconservation of Peptide Extracts From Trypsin Digestion of Proteins for Proteomic Analysis in a Hospital Biobank Facility

  • Mateos, Jesús
  • Pintor-Iglesias, Alejandra
  • Fernández-Puente, Patricia
  • García-Camba, Marta
  • Ruiz-Romero, Cristina
  • Doménech, Nieves
  • Blanco García, Francisco J
This document is the Accepted Manuscript version of a Published Article that appeared in final form in Journal of Proteome Research, copyright © 2014 American Chemical Society. To access the final published article, see ACS Articles on Request., [Abstract] We tested a semiautomated protocol for the proper storage and conservation in a hospital biobank of tryptic peptide extracts coming from samples with low and high protein complexity for subsequent mass spectrometry analysis. Low-complexity samples (serum albumin, serotransferrin. and alpha-S1-casein) were loaded in replicates in SDS-PAGE and subjected to standard in-gel trypsin digestion. For LC-MALDI-TOF/TOF analysis, purified β-galactosidase and human serum samples were in-solution digested following standard procedures and desalted with C18 stage-tips. In both cases, peptides extracts were aliquoted in individually 2D coded tubes, vacuum-dried, barcode-read, and stored in an automated -20 °C freezer in the Biobank facility. Samples were kept dried at -20 °C until the corresponding time-point of analysis, then reconstituted in the proper buffer and analyzed by either MALDI-TOF/TOF (peptide fingerprinting and MS/MS) or LC-MALDI-TOF/TOF following a highly reproducible pattern to ensure the reproducibility of the results. Protein identification was done with either Mascot or Protein Pilot as search engines using constant parameters. Over a period of 1 year we checked six different time points at days 0, 7, 30, 90, 180, and 365. We compared MS and MS/MS protein score, number of identified peptides, and coverage of the identified proteins. In the low complexity samples, the number of peptides detected gradually decreased over time, especially affecting the MS score. However, two of the three proteins - serum albumin and serotransferrin - were identified by both PMF and MS/MS at day 90. By day 180, only MS/MS identification in some replicates was possible. By LC-MS/MS, β-galactosidase and the most abundant serum proteins were identified with good scores at all time points even by day 365, with no detectable peptide loss or decrease in the fragmentation efficiency, although a progressive decrease in peptide intensity indicates that detection of low abundant proteins could not be optimal after very long periods of time. Our results encourage us to use the biobank facility in the future for long-term storage - up to 3 months - of dried peptide extracts., This study was funded by grants from Fondo Investigacion Sanitaria-Spain (CP09/00114, PI11/02397, PI12/00329) and Secretaria I+D+I Xunta de Galicia (10CSA916058PR). J.M. (CA11/00050) and P.F.-P. (CA09/00458) are supported by Fondo Investigacion Sanitaria-Spain. C.R.-R. is supported by the Miguel Servet program from Fondo Investigacion Sanitaria-Spain (CP09/00114). This study is integrated into the chromosome 16 Spanish Human Proteome Project. ProteoRed is part of the Biomolecular and Bioinformatics Resources Platform, PRB2-ISCIII, supported by grant (ISCIII, PT13/0001 from the Carlos III National Health Institute).
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Lessons from the proteomic study of osteoarthritis

  • Ruiz-Romero, Cristina
  • Fernández-Puente, Patricia
  • Calamia, Valentina
  • Blanco García, Francisco J
Review, [Abstract] Osteoarthritis is the most common rheumatic pathology and one of the leading causes of disability worldwide. It is a very complex disease whose etiopathogenesis is not fully understood. Furthermore, there are serious limitations for its management, since it lacks specific and sensitive biomarkers for early diagnosis, prognosis and therapeutic monitoring. Proteomic approaches performed in the last few decades have contributed to the knowledge on the molecular mechanisms that participate in this pathology and they have also led to interesting panels of putative biomarker candidates. In the next few years, further efforts should be made for translating these findings into the clinical routines. It is expected that targeted proteomics strategies will be highly valuable for the verification and qualification of biomarkers of osteoarthritis., This work is funded by grants from Fondo Investigación Sanitaria-Spain (PI11/02397, PI12/00329 and PI14/01707). C. Ruiz-Romero is supported by the Miguel Servet program from Fondo Investigación Sanitaria, Spain (CP09/00114).
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Analysis of Autoantibody Profiles in Osteoarthritis Using Comprehensive Protein Array Concepts

  • Henjes, Frauke
  • Lourido, Lucía
  • Ruiz-Romero, Cristina
  • Fernández-Tajes, Juan
  • Schwenk, Jochen M.
  • González-González, María
  • Blanco García, Francisco J
  • Nilsson, Peter
  • Fuentes, Manuel
[Abstract] Osteoarthritis (OA) is the most common rheumatic disease and one of the most disabling pathologies worldwide. To date, the diagnostic methods of OA are very limited, and there are no available medications capable of halting its characteristic cartilage degeneration. Therefore, there is a significant interest in new biomarkers useful for the early diagnosis, prognosis, and therapeutic monitoring. In the recent years, protein microarrays have emerged as a powerful proteomic tool to search for new biomarkers. In this study, we have used two concepts for generating protein arrays, antigen microarrays, and NAPPA (nucleic acid programmable protein arrays), to characterize differential autoantibody profiles in a set of 62 samples from OA, rheumatoid arthritis (RA), and healthy controls. An untargeted screen was performed on 3840 protein fragments spotted on planar antigen arrays, and 373 antigens were selected for validation on bead-based arrays. In the NAPPA approach, a targeted screening was performed on 80 preselected proteins. The autoantibody targeting CHST14 was validated by ELISA in the same set of patients. Altogether, nine and seven disease related autoantibody target candidates were identified, and this work demonstrates a combination of these two array concepts for biomarker discovery and their usefulness for characterizing disease-specific autoantibody profiles., We gratefully acknowledge financial support from Euro-TEAM (EU FP7), Knut and Alice Wallenberg Foundation, SciLifeLab Stockholm, the Carlos III Health Institute of Spain (FIS PI11/02114, PI11/02397, PI12/00329; CIBER-CB06/01/0040; RETIC-RIER-RD12/0009/0018), FEDER (European Community), Xunta de Galicia (Red Gallega REDICENT), and Junta Castilla-León SA198A12-2. The Proteomics Unit at CIC belongs to ProteoRed, PRB2-ISCIII, supported by grant PT13/0001.
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Secretome analysis of human articular chondrocytes unravels catabolic effects of nicotine on the joint

  • Lourido Salas, Lucía María
  • Calamia, Valentina
  • Fernández-Puente, Patricia
  • Mateos, Jesús
  • Oreiro Villar, Natividad
  • Blanco García, Francisco J
  • Ruiz-Romero, Cristina
[Abstract] Purpose: Osteoarthritis (OA) is a degenerative joint pathology characterized by articular cartilage degradation that lacks from efficient therapy. Since previous epidemiological data show a high controversy regarding the role of smoking in OA, we aimed to evaluate the effects of nicotine (the most physiologically active compound of tobacco) on the joint. Experimental design: Secretome analyses, based on metabolic labeling followed by LC-MALDI-TOF/TOF analysis, were carried out using an in vitro model of articular inflammation (primary human articular chondrocytes treated with interleukin-1β), and also on osteoarthritic cells. ELISA and Western blot assays were performed to verify some of the results. Results: Nineteen proteins were altered by nicotine in the model of articular inflammation, including several cytokines and proteases. We confirmed the increased secretion by nicotine of matrix metalloproteinase 1 and two proposed markers of OA, fibronectin, and chitinase 3-like protein 1. Finally, four components of the extracellular matrix of cartilage were decreased by nicotine in OA chondrocytes. Conclusions and clinical relevance: Our data contribute to a better understanding of the molecular mechanisms that are modulated by nicotine in cartilage cells, suggesting a negative effect of this drug on the joint., This study was supported by grants from Fondo Investigación Sanitaria-Spain (CP09/00114, PI11/02397, PI12/00329, PI14/01707, CIBER-CB06/01/0040, RETIC-RIER-RD12/0009/0018, and Proteo-Red/ISCIII) and Xunta de Galicia (10CSA916058PR, 10PXIB310153PR, REDICENT and REGICC). L.L. was supported by Xunta de Galicia. C. R.-R. is supported by Fondo Investigación Sanitaria-Spain (Miguel Servet program, CP09/00114).
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Characterization of lipidic markers of chondrogenic differentiation using mass spectrometry imaging

  • Rocha Loureda, Beatriz
  • Cillero-Pastor, B.
  • Eijkel, Gert
  • Bruinen, Anne L.
  • Ruiz-Romero, Cristina
  • Heeren, Ron M.A.
  • Blanco García, Francisco J
[Abstract] Mesenchymal stem cells (MSC) are an interesting alternative for cell-based therapy of cartilage defects attributable to their capacity to differentiate toward chondrocytes in the process termed chondrogenesis. The metabolism of lipids has recently been associated with the modulation of chondrogenesis and also with the development of pathologies related to cartilage degeneration. Information about the distribution and modulation of lipids during chondrogenesis could provide a panel of putative chondrogenic markers. Thus, the discovery of new lipid chondrogenic markers could be highly valuable for improving MSC-based cartilage therapies. In this work, MS imaging was used to characterize the spatial distribution of lipids in human bone marrow MSCs during the first steps of chondrogenic differentiation. The analysis of MSC micromasses at days 2 and 14 of chondrogenesis by MALDI-MSI led to the identification of 20 different lipid species, including fatty acids, sphingolipids, and phospholipids. Phosphocholine, several sphingomyelins, and phosphatidylcholines were found to increase during the undifferentiated chondrogenic stage. A particularly detected lipid profile was verified by TOF secondary ion MS. Using this technology, a higher intensity of phosphocholine-related ions was observed in the peripheral region of the micromasses collected at day 14., his work was supported in part through funding from EU COST Action BM1104 (Mass Spectrometry Imaging: new tools for healthcare research), and also from Fondo Investigación Sanitaria, Madrid, Spain (CIBER-CB06/01/0040; PI12/00329; PI11/02397, RETIC-RIER-RD12/0009/0018; Proteo-Red/ISCIII); FEDER (European Community), Xunta de Galicia (Red Gallega REDICENT) and Dutch national program COMMIT.